- Home
- BMY vs BUD Comparison
BMY vs BUD Comparison
Compare BMY & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- BUD
- Stock Information
- Founded
- BMY 1887
- BUD 1366
- Country
- BMY United States
- BUD Belgium
- Employees
- BMY N/A
- BUD N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- BUD Beverages (Production/Distribution)
- Sector
- BMY Health Care
- BUD Consumer Staples
- Exchange
- BMY Nasdaq
- BUD Nasdaq
- Market Cap
- BMY 120.5B
- BUD 121.9B
- IPO Year
- BMY N/A
- BUD N/A
- Fundamental
- Price
- BMY $47.88
- BUD $65.01
- Analyst Decision
- BMY Hold
- BUD Buy
- Analyst Count
- BMY 16
- BUD 3
- Target Price
- BMY $58.93
- BUD $64.00
- AVG Volume (30 Days)
- BMY 15.2M
- BUD 2.9M
- Earning Date
- BMY 04-24-2025
- BUD 05-07-2025
- Dividend Yield
- BMY 5.18%
- BUD 1.59%
- EPS Growth
- BMY N/A
- BUD 10.00
- EPS
- BMY 2.67
- BUD 2.86
- Revenue
- BMY $47,636,000,000.00
- BUD $59,768,000,000.00
- Revenue This Year
- BMY N/A
- BUD $1.64
- Revenue Next Year
- BMY N/A
- BUD $4.53
- P/E Ratio
- BMY $17.94
- BUD $23.02
- Revenue Growth
- BMY 4.62
- BUD 0.65
- 52 Week Low
- BMY $39.35
- BUD $45.94
- 52 Week High
- BMY $63.33
- BUD $67.49
- Technical
- Relative Strength Index (RSI)
- BMY 26.51
- BUD 60.07
- Support Level
- BMY $46.93
- BUD $65.14
- Resistance Level
- BMY $50.06
- BUD $66.38
- Average True Range (ATR)
- BMY 2.18
- BUD 1.27
- MACD
- BMY -0.35
- BUD 0.21
- Stochastic Oscillator
- BMY 10.75
- BUD 76.44
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.